Surgeons at Penn State Heart and Vascular Institute were the second group in the nation to implant a newly-designed mechanical pump in a patient with severe heart failure. The EvaHeart2 Left Ventricular Assist System (LVAD), can be used as a destination therapy and as a bridge to transplant.
Rob Dowling, M.D., director of heart device research at Penn State Heart and Vascular Institute and Penn State College of Medicine, explains the benefits of the new LVAD system. He was one of the cardiothoracic surgeons who implanted the pump and said the EvaHeart2 left ventricular assist system was designed to reduce the risk of post-implantation stroke, which affects approximately 8% of heart failure patients implanted with an LVAD.
The flush inflow ostium in the left ventricle, low profile inflow design, rotational apex suture cuff are designed to be forgiving on possible inflow cannula malposition and to minimize the risk of wedge thrombus.
“Imagine inserting the tip of a vacuum cleaner into the left ventricle of the heart to get the blood to the pump and out to the rest of the body,” Dowling said. “Sometimes the tip can move into an incorrect position even after proper surgical placement and can create suction against the walls of the heart. This may create blood clots that could cause strokes. This new device was designed in such a way that there is no tip, but rather the “vacuum” hose itself is surgically attached directly to into the lining of the walls of the heart, removing the need for a tip and thereby potentially reducing the risk of stroke.”
The procedure was part of the COMPETENCE Trial, a multi-center clinical study to evaluate EvaHeart2 that will include 40 clinical sites and 399 patients with severe heart failure through 2022.
Richard Huggins, 75, of Lock Haven, Pa., was the second patient in the nation to receive the EvaHeart2 Left Ventricular Assist System (LVAS). Surgeons at Penn State Heart and Vascular Institute implanted the device on Jan. 13.
Read more in the article Hershey Medical Center Second in the Nation to Implant EvaHeart2 LVAD.
Recent Videos View all 644 items
Managing Acute Coronary Syndromes in Women: Why and When is a Unique Approach Required features an in-depth interview with Malissa J. Wood, MD, FACC. Wood is the co-director of the Corrigan Women’s Heart Health Program at Massachusetts General Hospital Heart Center, and associate professor at Harvard Medical School. Here, she offers detailed guidance to cardiologists for improving the diagnosing and treatment of heart disease in women. Wood serves as the American College of Cardiology, ACC Chair, Board of Governors, and Secretary, Board of Trustees (2022-2023). This video interview is part of DAIC's One on One ... feature series that profiles a leader in cardiology to share insight, updates and initiatives on a range of hot topics impacting the cardiology community. The series also includes a feature profile and podcast.
Related content:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: Unique Features of Coronary Artery Disease in Women
Treatment for Heart Attacks Improving but Gaps in Access Persist, New Study Shows
Closing the Gap in Healthcare by Addressing Gender Bias
Diagnostic Differences in Women’s Heart Health
VIDEO: Differences in Cardiac Complications and Presentation Between Men and Women — Interview with Cindy Grines, M.D.
DAIC's Women's Cardiovascular Health Channel
VIDEO: How to Build a Successful Women’s Heart Center — Interview with Malissa Wood, M.D.
VIDEO: Creating a Cardio-Obstetrics Team — Doreen DeFaria Yeh, M.D.
Related Content on New Technology and Ideas to Address Health Disparities:
VIDEO: New Ideas in Addressing Cardiovascular Disease Disparities — Clyde Yancy, M.D
VIDEO: How Smartphones May Revolutionize Healthcare in the Developing World —Interview with Jacques Kpodonu, M.D.
VIDEO: Reducing Hypertension Among African-Americans — Interview with Kim Allan Williams, Sr., M.D.
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Sponsored Videos View all 46 items
Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.
Watch the video to check out how TrueVue can help improve views of LAA and MV morphology.
Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*
Watch the video to see how you can put “smart” to work with the latest AI-powered quantification tools.
*External study with external sonographers comparing the results of 18 exams with and without AutoMeasure
The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer.
Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more.
Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.
Conference Coverage View all 460 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Cath Lab View all 316 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Cardiac Imaging View all 287 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Cardiac Diagnostics View all 78 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
EP Lab View all 83 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Information Technology View all 169 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)